CC News

Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director

CC

(NYSE:CC) WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) today announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act. “While

September 3, 2025Governance
Read more →

Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals

CC

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals

Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026

CC

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026

The Chemours Company Reports Second Quarter 2025 Results

CC

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Second Quarter 2025 Results

August 5, 2025Earnings
Read more →

Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS

CC

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours, DuPont and Corteva Reach Agreement with the State of New Jersey to Comprehensively Resolve All Environmental Claims Including PFAS

August 4, 2025Legal
Read more →

The Chemours Company Provides Update on Second Quarter 2025 Outlook

CC

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Provides Update on Second Quarter 2025 Outlook

Chemours Appoints Matthew Conti as Chief Human Resources Officer

CC

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Matthew Conti as Chief Human Resources Officer

Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

CC

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Technology and Data Center Infrastructure Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio

Assessing Chemours: Insights From 8 Financial Analysts

CC

May 28, 2025
Read more →

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $13

CC

May 28, 2025
Read more →

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields

CC

May 28, 2025
Read more →

Chemours Company Announces Strategic Agreement With DataVolt To Further Demonstrate, Develop Advanced Liquid Cooling Solutions For Data Centers

CC

May 19, 2025
Read more →

Goldman Sachs Maintains Neutral on Chemours, Lowers Price Target to $14

CC

May 14, 2025
Read more →

Morgan Stanley Maintains Equal-Weight on Chemours, Lowers Price Target to $15

CC

May 12, 2025
Read more →

RBC Capital Maintains Outperform on Chemours, Lowers Price Target to $14

CC

May 8, 2025
Read more →

6 Analysts Assess Chemours: What You Need To Know

CC

May 7, 2025
Read more →

UBS Maintains Buy on Chemours, Lowers Price Target to $17

CC

May 7, 2025
Read more →

Chemours Announces Strategic Agreement With Navin Fluorine International To Manufacture Opteon Two-Phase Immersion Cooling Fluid

CC

May 6, 2025
Read more →

Chemours Q1 Adj. EPS $0.13 Misses $0.21 Estimate, Sales $1.37B Beat $1.35B Estimate

CC

May 6, 2025
Read more →

Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 7% Dividend Yields

CC

April 24, 2025
Read more →

What 6 Analyst Ratings Have To Say About Chemours

CC

April 14, 2025
Read more →

Truist Securities Maintains Buy on Chemours, Lowers Price Target to $22

CC

April 14, 2025
Read more →

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $16

CC

April 1, 2025
Read more →

This Check Point Software Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday

CC

March 27, 2025
Read more →

The Analyst Verdict: Chemours In The Eyes Of 7 Experts

CC

March 27, 2025
Read more →

Mizuho Upgrades Chemours to Outperform, Maintains Price Target to $19

CC

March 27, 2025
Read more →

Chemours, Energy Fuels Team Up to Advance Domestic Rare Earth Production

CC

Chemours and Energy Fuels partner to boost US domestic supply chains for rare earth elements and minerals. Collaboration to support White Mesa Mill.

March 18, 2025
Read more →

Chemours Partners With Energy Fuels To Form A Domestic Supply Chain Of Critical Minerals For US

CC

March 18, 2025
Read more →

Chemours Leads Product Trial to Cut Data Center Cooling Energy Use by 90%: Details

CC

Chemours joins forces with NTT DATA and Hibiya Engineering, Ltd. to advance data center two-phase immersion cooling with Opteon 2P50.

March 14, 2025
Read more →

The Chemours Company Launches Full-Scale Product Trial For Data Center Two-Phase Immersion Cooling with NTT DATA And Hibiya Engineering, Utilizing Opteon 2P50 FluiW

CC

March 14, 2025
Read more →

Deep Dive Into Chemours Stock: Analyst Perspectives (7 Ratings)

CC

February 24, 2025
Read more →

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $19

CC

February 24, 2025
Read more →

BMO Capital Maintains Outperform on Chemours, Lowers Price Target to $27

CC

February 19, 2025
Read more →

The Chemours Company Announced The Launch Of Ti-Pure TS-6706, A TMP- And TME- Free Version Of Ti-Pure R-706 – The Benchmark, Universal Titanium Dioxide Grade That Works Reliably For A Variety Of Coatings Applications Where Appearance Is Critical

CC

February 19, 2025
Read more →

Chemours Q4 Earnings: Mixed Results, Moderate Outlook, 'Pathway To Thrive' In Action & More

CC

Chemours Company reports Q4 net sales of $1.359 billion, in line with consensus. Adjusted EBITDA improved 2% Y/Y. FY25 outlook positive.

February 18, 2025
Read more →

Chemours Anticipates Q1 Consolidated Net Sales To Be Flat To Slightly Down Sequentially, With Adjusted EBITDA To Be Slightly Down Sequentially

CC

February 18, 2025
Read more →

Chemours Expects FY25 Adjusted EBITDA Of $825M - $975M, Capital Expenditures Of $250M - $300M

CC

February 18, 2025
Read more →

Chemours Q4 2024 Adj EPS $0.11 Misses $0.12 Estimate, Sales $1.36B Inline

CC

February 18, 2025
Read more →

A Glimpse Into The Expert Outlook On Chemours Through 7 Analysts

CC

January 13, 2025
Read more →

Morgan Stanley Maintains Equal-Weight on Chemours, Lowers Price Target to $22

CC

January 13, 2025
Read more →

Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks Delivering High-Dividend Yields

CC

December 20, 2024
Read more →

RBC Capital Maintains Outperform on Chemours, Lowers Price Target to $25

CC

November 6, 2024
Read more →

What Analysts Are Saying About Chemours Stock

CC

November 5, 2024
Read more →

Barclays Maintains Equal-Weight on Chemours, Raises Price Target to $23

CC

November 5, 2024
Read more →

Morgan Stanley Maintains Equal-Weight on Chemours, Lowers Price Target to $25

CC

November 5, 2024
Read more →

Chemours Sees Incremental Run-Rate Cost Savings Of > $250M Across From 2024-2027

CC

November 4, 2024
Read more →

Chemours Sees Q4 Net Sales Decrease In Mid To High-Single Digits Sequentially

CC

November 4, 2024
Read more →